Stay updated on Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T06:59:28.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added and Revision: v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-10T15:40:52.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Administrative revision updates were applied: Revision v3.4.2 was added and Revision v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-17T03:05:12.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed the government-funding notice and the earlier Revision: v3.4.0 entry.
    Difference
    0.1%
    Check dated 2026-02-09T21:40:17.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding has been added, informing users that information on the site may not be up to date and that the NIH Clinical Center is open, with links for further details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-02T17:35:57.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    Added a glossary display option and updated revision and QC-related labels (Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0). Removed the older variants of these entries (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-26T16:00:32.000Z thumbnail image

Stay in the know with updates to Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.